Drugs / Ciclopirox Olamine

Trials 3 · a red edge is where a trial was stopped

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00990587 Oct 2009 → May 2013 Hodgkins lymphoma, acute myeloid leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, chronic myeloid leukemia +1 University Health Network, Toronto Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00802672 Dec 2003 → May 2004 tinea pedis Padagis LLC Completed No outcome recorded
Phase 41 trial
Phase 4 NCT01014637 Aug 2009 → Sep 2011 tinea unguium Pierre Fabre Dermo Cosmetique Unknown No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT02004860 Comparator Jan 2014 → Oct 2017 seborrheic dermatitis University Hospital, Rouen Completed No outcome recorded
Phase 41 trial
Phase 4 NCT01139749 Comparator Oct 2011 → Jul 2012 seborrheic dermatitis Federal University of São Paulo Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Ciclopiroxolamine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01014637
3

NCT00802672

NCT00990587

NCT01139749

Known as Mycoster ClinicalTrials.gov intervention name — accepted as the source's own label NCT02004860
Route Topical topical cream” NCT00802672